The global transcriptomics
technologies market is expected to reach USD 6.9 billion by 2022, according to
a new report by Grand View Research Inc. The increasing demand for genetic
identification and growing investment in R&D innovation along with the technological
advancements across the product portfolio are the vital driving forces of this
market. The increasing R&D investments are expected to highly influence
biotechnological research and develop the commercialization over the forecast
period. The rising investment is further anticipated to ensure positive growth
and enhance business opportunities for pharmaceutical and biotechnological
companies.
Furthermore, the rising
demand for efficient diagnostic methods drives the need for personalized
medicines. Transcriptomics tools and the offered services identify potential
drug targets, which are effective methods for diagnostic methodologies. The
shifting preference of pharmaceutical companies towards therapeutics results in
rising demand for the disease specific biomarker identification. This change
ensures a potential opportunity in the commercialization of transcriptome
research results. The escalating demand for efficient diagnostics and treatment
measures in the areas of oncology, HIV, Alzheimer’s disease, etc., also
contributes significantly towards transcriptomics technologies market growth.
In depth research report on Transcriptomics Technologies
Market
Further key findings from the report suggest:
·
Polymerase Chain Reaction
(PCR) based transcriptomics technologies market is expected to account for over
40% market share by 2022 owing to its ability to enable amplification even from
very small amounts of genetic material samples
·
Next Generation Sequencing
based transcriptomics technologies market is expected to grow at a lucrative
CAGR of over 17.0% over the forecast period owing to increased outsourcing of
sequencing technologies, upgrading of technology enabling the analysis of
cellular transcriptome from various dimensions, and wide application areas of
NGS
·
North America dominates the
transcriptomics technologies market in terms of revenue owing to the increasing
R&D activities by the biotechnology and pharmaceutical companies
·
North America and Asia
Pacific are expected to witness fastest growth of over 15.0% during the
forecast period. The growth is due to the presence of untapped opportunities,
rising expenditure level, and the introduction of favorable government
initiatives.
·
Key players of
transcriptomics technologies market include Agilent Technologies, Affymetrix,
Thermo Fisher Scientific, Illumina, Life Technologies, and F. Hoffmann-La Roche
·
Market participants are
constantly engaged in strategic collaborations such as mergers and acquisitions
along with technological advancements in an attempt to improve presence and
ensure sustainability
·
For instance, in May 2015,
Agilent Technologies announced the acquisition of Cartagenia that provides
services and software for clinical genetic analysis. Their products are
supplied to pathology laboratories and clinical research institutes. The
acquisition is expected to provide higher integration and support customer
satisfaction.
Grand View Research has
segmented the global transcriptomics technologies market on the basis of
technology, applications, and region:
Transcriptomics Technology Outlook (Revenue, USD Million,
2012 - 2022)
·
Microarray
·
PCR
·
Gene Regulation Technologies
·
Next Generation Sequencing
Transcriptomics Technology Application (Revenue, USD
Million, 2012 - 2022)
·
Clinical Diagnostics
·
Drug Discovery and Research
·
Bioinformatics
·
Comparative Transcriptomics
Transcriptomics Technologies Regional Outlook (Revenue,
USD Million, 2012 - 2022)
·
North America
·
Europe
·
Asia Pacific
·
RoW
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment